This company has been acquired
Forian (FORA) Aperçu de l'action
Forian Inc. fournit un ensemble de capacités de gestion de données et de solutions d'information et d'analyse exclusives pour optimiser et mesurer les performances opérationnelles, cliniques et financières. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 2/6 |
| Croissance future | 0/6 |
| Performances passées | 0/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
FORA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Forian Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$2.17 |
| Plus haut sur 52 semaines | US$2.71 |
| Plus bas sur 52 semaines | US$1.64 |
| Bêta | 0.93 |
| Variation sur 1 mois | 0.46% |
| Variation sur 3 mois | 3.33% |
| Variation sur 1 an | 0.93% |
| Variation sur 3 ans | -9.01% |
| Variation sur 5 ans | -78.06% |
| Évolution depuis l'introduction en bourse | -90.52% |
Nouvelles et mises à jour récentes
FORA: Maryland Governance Shift And Assumption Tweaks Will Shape Balanced Outlook
Forian's updated analyst price target in $ has shifted slightly, with analysts citing modest adjustments to the discount rate, profit margin assumptions and the expected future P/E as the main factors driving the revision. What's in the News On January 8, 2026, Forian stockholders approved a change so the company is no longer governed by its existing certificate of incorporation and bylaws and is now governed by a Maryland Charter and Maryland Bylaws (Key Developments).FORA: Maryland Move And Updated Assumptions Will Shape Balanced Forward Outlook
Analysts have adjusted their price target for Forian to $2.10 per share. This reflects updated assumptions for the discount rate, profit margin and future P/E, while keeping fair value per share broadly aligned with prior estimates.FORA: Maryland Redomicile And Stable Assumptions Will Support Balanced Forward Outlook
Analysts have made a modest adjustment to their fair value view on Forian, with a slightly lower discount rate and virtually unchanged revenue growth, profit margin, and future P/E assumptions guiding the latest price target update in dollar terms. What's in the News Stockholders approved a change in governing documents on January 8, 2026, moving Forian from its existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.FORA: Maryland Redomicile And Data Investment Will Support Steady Forward Outlook
Analysts have trimmed their price target on Forian to US$2.10 from US$2.20, citing slightly lower assumed discount rates and modest adjustments to long term revenue growth, profit margin and future P/E expectations. What's in the News Stockholders approved a change in Forian's governing documents on January 8, 2026, moving from the existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.Recent updates
FORA: Maryland Governance Shift And Assumption Tweaks Will Shape Balanced Outlook
Forian's updated analyst price target in $ has shifted slightly, with analysts citing modest adjustments to the discount rate, profit margin assumptions and the expected future P/E as the main factors driving the revision. What's in the News On January 8, 2026, Forian stockholders approved a change so the company is no longer governed by its existing certificate of incorporation and bylaws and is now governed by a Maryland Charter and Maryland Bylaws (Key Developments).FORA: Maryland Move And Updated Assumptions Will Shape Balanced Forward Outlook
Analysts have adjusted their price target for Forian to $2.10 per share. This reflects updated assumptions for the discount rate, profit margin and future P/E, while keeping fair value per share broadly aligned with prior estimates.FORA: Maryland Redomicile And Stable Assumptions Will Support Balanced Forward Outlook
Analysts have made a modest adjustment to their fair value view on Forian, with a slightly lower discount rate and virtually unchanged revenue growth, profit margin, and future P/E assumptions guiding the latest price target update in dollar terms. What's in the News Stockholders approved a change in governing documents on January 8, 2026, moving Forian from its existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.FORA: Maryland Redomicile And Data Investment Will Support Steady Forward Outlook
Analysts have trimmed their price target on Forian to US$2.10 from US$2.20, citing slightly lower assumed discount rates and modest adjustments to long term revenue growth, profit margin and future P/E expectations. What's in the News Stockholders approved a change in Forian's governing documents on January 8, 2026, moving from the existing certificate of incorporation and bylaws to a Maryland Charter and Maryland Bylaws.FORA: Maryland Move And Data Investments Will Support Balanced Forward Outlook
Analysts have slightly reduced their price target on Forian to account for minor changes in key model inputs such as the discount rate and forward P/E, while maintaining their estimate of fair value at US$2.10 per share. What's in the News Stockholders approved Forian's move to be governed by a Maryland Charter and Maryland Bylaws, replacing its prior certificate of incorporation and bylaws, following a special meeting held on January 8, 2026 (company announcement).FORA: Data Investments And Redomiciling Vote Will Shape Balanced Future Outlook
Analysts have modestly adjusted their price target for Forian, reflecting slightly higher assumed discount rates, a small change in long term profit margin expectations, and a marginally richer future P/E multiple in their updated models. What's in the News Forian has called a special or extraordinary shareholders meeting for January 8, 2026, at 12:00 US Eastern Standard Time to consider a proposal to redomicile from Delaware to Maryland through a statutory conversion (Key Developments).FORA: Guidance And Data Investments Will Shape Outlook Ahead Of Shareholder Meeting
Analysts have modestly raised their price target on Forian to reflect a slightly higher future earnings multiple of about 29.7 times. At the same time, largely unchanged fair value and growth assumptions indicate a more measured optimism about the company’s long term profit trajectory.FORA: Guidance, Data Investments And Shareholder Meeting Will Shape Balanced Outlook
Analysts have raised their price target on Forian modestly, citing a slightly higher discount rate and marginally improved expectations for long term profitability and valuation multiples. Together, these factors support a fair value of approximately 2.10 dollars per share.FORA: Share Buyout Bid And Evolving Guidance Will Shape Outlook
Analysts have significantly reduced their price target for Forian from $5.00 to $2.10 per share, citing lower expected revenue growth and profit margins as the primary factors for the revision. What's in the News A consortium led by Max Wygod has announced plans to acquire the remaining 37% stake in Forian Inc.Health Check: How Prudently Does Forian (NASDAQ:FORA) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Investors Aren't Entirely Convinced By Forian Inc.'s (NASDAQ:FORA) Revenues
There wouldn't be many who think Forian Inc.'s ( NASDAQ:FORA ) price-to-sales (or "P/S") ratio of 2.8x is worth a...There's Reason For Concern Over Forian Inc.'s (NASDAQ:FORA) Massive 30% Price Jump
The Forian Inc. ( NASDAQ:FORA ) share price has done very well over the last month, posting an excellent gain of 30...
Integration Of Kyber Data Science Will Provide Differentiated Value To Customers
The acquisition of Kyber Data Science and strategic partnerships are expected to enhance market reach and shareholder value, driving revenue growth.The Consensus EPS Estimates For Forian Inc. (NASDAQ:FORA) Just Fell A Lot
Market forces rained on the parade of Forian Inc. ( NASDAQ:FORA ) shareholders today, when the covering analyst...Forian (NASDAQ:FORA) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Investors were disappointed with Forian Inc.'s ( NASDAQ:FORA ) earnings, despite the strong profit numbers. Our...Unpleasant Surprises Could Be In Store For Forian Inc.'s (NASDAQ:FORA) Shares
Forian Inc.'s ( NASDAQ:FORA ) price-to-sales (or "P/S") ratio of 4.4x may look like a poor investment opportunity when...Is Forian (NASDAQ:FORA) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Investors Give Forian Inc. (NASDAQ:FORA) Shares A 28% Hiding
The Forian Inc. ( NASDAQ:FORA ) share price has fared very poorly over the last month, falling by a substantial 28...Rendement pour les actionnaires
| FORA | US Healthcare Services | US Marché | |
|---|---|---|---|
| 7D | 0.9% | -0.8% | 2.5% |
| 1Y | 0.9% | -40.0% | 26.4% |
Rendement vs Industrie: FORA a dépassé le secteur US Healthcare Services qui a rapporté -38.4 % au cours de l'année écoulée.
Rendement vs marché: FORA a sous-performé le marché US qui a rapporté 28.7 % au cours de l'année écoulée.
Volatilité des prix
| FORA volatility | |
|---|---|
| FORA Average Weekly Movement | 1.5% |
| Healthcare Services Industry Average Movement | 10.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.1% |
Cours de l'action stable: FORA n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de FORA a diminué de 7% à 1% au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2020 | 50 | Max Wygod | forian.com |
Forian Inc. propose un ensemble de capacités de gestion de données et de solutions d'information et d'analyse exclusives pour optimiser et mesurer les performances opérationnelles, cliniques et financières. Elle développe des solutions commerciales, des solutions d'accès au marché et des solutions basées sur des données exclusives. Les solutions de la société, basées sur l'abonnement et les services, sont destinées aux sciences de la vie, aux services pharmaceutiques, aux payeurs de soins de santé, ainsi qu'aux fournisseurs et aux services financiers.
Forian Inc. Résumé des fondamentaux
| FORA statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$67.79m |
| Bénéfices(TTM) | -US$2.87m |
| Recettes(TTM) | US$30.26m |
Le site FORA est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| FORA compte de résultat (TTM) | |
|---|---|
| Recettes | US$30.26m |
| Coût des recettes | US$14.16m |
| Marge brute | US$16.10m |
| Autres dépenses | US$18.97m |
| Les revenus | -US$2.87m |
Derniers bénéfices déclarés
Dec 31, 2025
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | -0.092 |
| Marge brute | 53.21% |
| Marge bénéficiaire nette | -9.50% |
| Ratio dettes/capitaux propres | 0% |
Quelles ont été les performances à long terme de FORA?
Voir les performances historiques et les comparaisonsAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/16 00:18 |
| Cours de l'action en fin de journée | 2026/05/14 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Forian Inc. est couverte par 1 analystes. 0 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Richard Baldry | Roth Capital Partners |